(Boursier.com) — advicenne a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, informs its shareholders of the holding of its combined general meeting on June 8, 2023 at 10 a.m. at 262, rue du Faubourg Saint-Honoré – 75008 Paris – France.
The prior notice including the agenda and the text of the resolutions was published in the BALO on May 1, 2023. The notice of meeting was published in the BALO and in a legal announcements journal on May 19, 2023.
The preparatory documents for the meeting set out in article R. 22-10-23 of the French Commercial Code are posted on the company’s website (www.advicenne.com).
©2023 Boursier.com